Lymphoblastic Leukemia, Acute, With Lymphomatous Features; Lall

Table of contents:

Description
Related genes
Clinical Features
Incidence and onset information
Alternative Names
Researches and researchers
Gene Panels
Sources and references

Genes related to Lymphoblastic Leukemia, Acute, With Lymphomatous Features; Lall

JAK2
FGFR1
JAK3
ABL1
IL7R
JAK1
CRLF2

View recommended genes panels

Clinical Features

Phenotypes and symptoms related to Lymphoblastic Leukemia, Acute, With Lymphomatous Features; Lall

Lymphoma
T-cell acute lymphoblastic leukemias

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
— No data available about the known clinical features onset.

Alternative names

Lymphoblastic Leukemia, Acute, With Lymphomatous Features; Lall Is also known as lymphomatous all.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.

Lymphoblastic Leukemia, Acute, With Lymphomatous Features; Lall Recommended genes panels

Panel Name, Specifity and genes Tested/covered
JAK2 Genotyping (V617F). By Molecular Genetics Diagnostic Laboratory Detroit Medical Center University Laboratories (United States). JAK2 Specificity 100 % Genes 15 %
JAK2 Exon 12 Sequencing. By Molecular Genetics Diagnostic Laboratory Detroit Medical Center University Laboratories (United States). JAK2 Specificity 100 % Genes 15 %
MyeloidDx by NGS. By Molecular Genetics Diagnostic Laboratory Detroit Medical Center University Laboratories (United States). RUNX1, SF3B1, SRSF2, BRAF, SMC1A, STAG2, TP53, U2AF1, KDM6A, WT1, IKZF1, CALR, CBL, CBLB, SETBP1, FBXW7, CDKN2A, PHF6, ASXL1, CEBPA , (...) View the complete list with 32 more genes Panel complete gene list RUNX1, SF3B1, SRSF2, BRAF, SMC1A, STAG2, TP53, U2AF1, KDM6A, WT1, IKZF1, CALR, CBL, CBLB, SETBP1, FBXW7, CDKN2A, PHF6, ASXL1, CEBPA, BCOR, ZRSR2, CSF3R, SMC3, CUX1, BCORL1, TET2, DNMT3A, ETV6, EZH2, FLT3, GATA1, GATA2, GNAS, HRAS, IDH1, IDH2, JAK2, JAK3, KIT, KRAS, MPL, MYD88, ABL1, NOTCH1, NPM1, NRAS, PDGFRA, ATRX, PTEN, PTPN11, RAD21 Specificity 6 % Genes 43 %
MyeloidDx by NGS. By Molecular Genetics Diagnostic Laboratory Detroit Medical Center University Laboratories (United States). RUNX1, SF3B1, SRSF2, BRAF, SMC1A, STAG2, TP53, U2AF1, KDM6A, WT1, IKZF1, CALR, CBL, CBLB, SETBP1, CBLC, FBXW7, CDKN2A, PHF6, CEBPA , (...) View the complete list with 31 more genes Panel complete gene list RUNX1, SF3B1, SRSF2, BRAF, SMC1A, STAG2, TP53, U2AF1, KDM6A, WT1, IKZF1, CALR, CBL, CBLB, SETBP1, CBLC, FBXW7, CDKN2A, PHF6, CEBPA, BCOR, ZRSR2, CSF3R, SMC3, CUX1, BCORL1, DNMT3A, ETV6, EZH2, FLT3, GATA1, GATA2, GNAS, HRAS, IDH1, IDH2, JAK2, JAK3, KIT, KRAS, MPL, MYD88, ABL1, NOTCH1, NPM1, NRAS, PDGFRA, ATRX, PTEN, PTPN11, RAD21 Specificity 6 % Genes 43 %
JAK2 V617F Quantitative Assay. By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States). JAK2 Specificity 100 % Genes 15 %
Thrombocytosis Panel by next generation sequencing (NGS). By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States). THPO, CALR, JAK2, MPL Specificity 25 % Genes 15 %
Erythrocytosis Panel by next-generation sequencing (NGS). By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States). BPGM, EGLN1, VHL, EPAS1, EPOR, HBA1, HBA2, HBB, JAK2 Specificity 12 % Genes 15 %
JAK2. Complete sequencing. By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain). JAK2 Specificity 100 % Genes 15 %

You can get up to 327 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

OMIM MESH Genetic Syndrome Finder

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF SMITH-MAGENIS SYNDROME CRANIOECTODERMAL DYSPLASIA 2; CED2 STUVE-WIEDEMANN SYNDROME PSEUDOXANTHOMA ELASTICUM; PXE